Biofrontera Inc (BFRI)
1.08
-0.01
(-0.92%)
USD |
NASDAQ |
May 17, 16:00
1.08
0.00 (0.00%)
After-Hours: 20:00
Biofrontera Gross Profit Margin (Quarterly): 49.34% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 49.34% |
| September 30, 2023 | 48.40% |
| June 30, 2023 | 50.62% |
| March 31, 2023 | 47.35% |
| December 31, 2022 | 48.19% |
| September 30, 2022 | 48.52% |
| June 30, 2022 | 42.70% |
| Date | Value |
|---|---|
| March 31, 2022 | 47.18% |
| December 31, 2021 | 47.94% |
| September 30, 2021 | 47.16% |
| June 30, 2021 | 46.92% |
| March 31, 2021 | 45.81% |
| December 31, 2020 | 48.39% |
| September 30, 2020 | 68.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
42.70%
Minimum
Jun 2022
68.85%
Maximum
Sep 2020
49.10%
Average
48.06%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Avinger Inc | 19.62% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 74.85% |
| Xtant Medical Holdings Inc | 62.07% |
| Asensus Surgical Inc | -172.1% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -187.7% |
| Return on Assets | -52.48% |
| Return on Invested Capital | -166.8% |
| Profit Margin (Quarterly) | 33.28% |
| Operating Margin (Quarterly) | -36.48% |
| Return on Net Operating Assets | -89.44% |